ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML
Product details
Registration number: SIN17405P
Classification: Prescription Only
Active ingredients: Mirvetuximab soravtansine
Strength: 100mg/20mL
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Registrant: ABBVIE PTE. LTD.
ATC code: L01FX26
HSA approval date: 21 November 2025
Manufacturer(s): BSP Pharmaceuticals S.p.A.
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17405P
Classification: Prescription Only
What active ingredients and strength are recorded for ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Mirvetuximab soravtansine
Strength: 100mg/20mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INFUSION, SOLUTION CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBVIE PTE. LTD.
Which manufacturers and countries are listed for ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): BSP Pharmaceuticals S.p.A.
Manufacturing country/countries: ITALY
Where can I look up ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17405P or the exact product name ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML. The general register link does not preselect this product.
What are the source dates for this ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ELAHERE CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/20ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17405P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)